ION BLUE EncyclopediaHigh Evidence

GHRP-6

GHRP-6 is a synthetic hexapeptide growth-hormone secretagogue (a growth-hormone-secretagogue/ghrelin receptor agonist) studied in preclinical models and early human pharmacology. It is a research peptide and is not an approved therapeutic.

Evidence: Low

Reading time:1 min
Citations:2
Updated:June 29, 2026

Type

Peptide

Direct Answer

GHRP-6 is a synthetic hexapeptide growth-hormone secretagogue (a growth-hormone-secretagogue/ghrelin receptor agonist) studied in preclinical models and early human pharmacology. It is a research peptide and is not an approved therapeutic.

Summary Table

Evidence Level

High

Key Information

Classification

Emerging Research1 Mechanisms

Key Takeaways

  • GHRP-6 is a growth-hormone secretagogue (ghrelin-receptor agonist)
  • Evidence is limited to early human pharmacology and preclinical work
  • It is a research peptide not approved for human use

Scientific Overview

In Plain English

GHRP-6 is a lab-made peptide that prompts the pituitary to release growth hormone. It has been studied in animals and in small human pharmacology studies, but it is not an approved medicine.

Scientific Details

GHRP-6 is a growth-hormone-releasing peptide acting at the growth-hormone-secretagogue (ghrelin) receptor. A human pharmacokinetic study characterized its profile in healthy volunteers, and receptor/ligand reviews describe the secretagogue class. It is not an approved drug, and large human outcome studies are lacking.

How It Works

GHRP-6 is described in research as a growth-hormone-secretagogue (ghrelin) receptor agonist; in vitro work shows it activates this receptor, and its pharmacokinetics have been characterized in healthy volunteers.

Mechanism of Action

GH secretagogue activity

human

Research associates GHRP-6 with growth-hormone release via the growth-hormone-secretagogue (ghrelin) receptor.

Evidence Level

Human Evidence

An early pharmacokinetic study characterized GHRP-6 in healthy male volunteers.

Animal Evidence

Preclinical work describes growth-hormone-secretagogue receptor pharmacology.

Limitations

Human evidence is limited to early pharmacology; GHRP-6 is not an approved therapeutic, and outcome data are lacking.

References

  1. Pharmacokinetic study of Growth Hormone-Releasing Peptide 6 (GHRP-6) in nine male healthy volunteers. European Journal of Pharmaceutical Sciences.Human Studydoi:10.1016/j.ejps.2012.10.006
  2. Growth hormone secretagogue receptor family members and ligands. Endocrine.Reviewdoi:10.1385/ENDO:14:1:009

Alternative Names

  • Growth Hormone Releasing Peptide-6
  • GHRP6

Claim Boundaries

ION BLUE is an educational research aggregator. This content summarizes published scientific literature. It is not medically reviewed, is not medical advice, and is not a recommendation to use any substance. Several peptides discussed are research chemicals not approved for human use. Consult a licensed healthcare provider. This entry does not assert that GHRP-6 is safe or beneficial for any use and is not a recommendation to use it.

This page summarizes published research and is for informational purposes only; it is not medical advice.